STERIS (STE) Competitors $223.14 -1.61 (-0.71%) As of 01:11 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsDividendEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock STE vs. BDX, EW, IDXX, RMD, DXCM, PODD, BAX, HOLX, GMED, and MASIShould you be buying STERIS stock or one of its competitors? The main competitors of STERIS include Becton, Dickinson and Company (BDX), Edwards Lifesciences (EW), IDEXX Laboratories (IDXX), ResMed (RMD), DexCom (DXCM), Insulet (PODD), Baxter International (BAX), Hologic (HOLX), Globus Medical (GMED), and Masimo (MASI). These companies are all part of the "health care equipment" industry. STERIS vs. Becton, Dickinson and Company Edwards Lifesciences IDEXX Laboratories ResMed DexCom Insulet Baxter International Hologic Globus Medical Masimo STERIS (NYSE:STE) and Becton, Dickinson and Company (NYSE:BDX) are both large-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, community ranking, valuation, analyst recommendations, media sentiment, profitability and earnings. Do insiders and institutionals hold more shares of STE or BDX? 94.7% of STERIS shares are held by institutional investors. Comparatively, 87.0% of Becton, Dickinson and Company shares are held by institutional investors. 1.1% of STERIS shares are held by company insiders. Comparatively, 0.4% of Becton, Dickinson and Company shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth. Does the media prefer STE or BDX? In the previous week, Becton, Dickinson and Company had 13 more articles in the media than STERIS. MarketBeat recorded 31 mentions for Becton, Dickinson and Company and 18 mentions for STERIS. STERIS's average media sentiment score of 1.32 beat Becton, Dickinson and Company's score of 1.27 indicating that STERIS is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment STERIS 14 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Becton, Dickinson and Company 24 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Is STE or BDX a better dividend stock? STERIS pays an annual dividend of $2.28 per share and has a dividend yield of 1.0%. Becton, Dickinson and Company pays an annual dividend of $4.16 per share and has a dividend yield of 2.0%. STERIS pays out 48.4% of its earnings in the form of a dividend. Becton, Dickinson and Company pays out 69.1% of its earnings in the form of a dividend. Both companies have healthy payout ratios and should be able to cover their dividend payments with earnings for the next several years. STERIS has raised its dividend for 20 consecutive years and Becton, Dickinson and Company has raised its dividend for 53 consecutive years. Becton, Dickinson and Company is clearly the better dividend stock, given its higher yield and longer track record of dividend growth. Which has stronger earnings & valuation, STE or BDX? Becton, Dickinson and Company has higher revenue and earnings than STERIS. Becton, Dickinson and Company is trading at a lower price-to-earnings ratio than STERIS, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSTERIS$5.40B4.09$378.24M$4.7147.70Becton, Dickinson and Company$20.64B2.88$1.71B$6.0234.37 Which has more risk & volatility, STE or BDX? STERIS has a beta of 0.87, meaning that its stock price is 13% less volatile than the S&P 500. Comparatively, Becton, Dickinson and Company has a beta of 0.35, meaning that its stock price is 65% less volatile than the S&P 500. Do analysts rate STE or BDX? STERIS presently has a consensus price target of $258.75, indicating a potential upside of 15.18%. Becton, Dickinson and Company has a consensus price target of $272.86, indicating a potential upside of 31.89%. Given Becton, Dickinson and Company's stronger consensus rating and higher possible upside, analysts clearly believe Becton, Dickinson and Company is more favorable than STERIS.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score STERIS 0 Sell rating(s) 1 Hold rating(s) 4 Buy rating(s) 0 Strong Buy rating(s) 2.80Becton, Dickinson and Company 0 Sell rating(s) 0 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 3.00 Is STE or BDX more profitable? STERIS has a net margin of 8.66% compared to Becton, Dickinson and Company's net margin of 8.47%. Becton, Dickinson and Company's return on equity of 15.74% beat STERIS's return on equity.Company Net Margins Return on Equity Return on Assets STERIS8.66% 13.91% 8.64% Becton, Dickinson and Company 8.47%15.74%7.29% Does the MarketBeat Community favor STE or BDX? Becton, Dickinson and Company received 265 more outperform votes than STERIS when rated by MarketBeat users. Likewise, 62.46% of users gave Becton, Dickinson and Company an outperform vote while only 59.16% of users gave STERIS an outperform vote. CompanyUnderperformOutperformSTERISOutperform Votes33959.16% Underperform Votes23440.84% Becton, Dickinson and CompanyOutperform Votes60462.46% Underperform Votes36337.54% SummaryBecton, Dickinson and Company beats STERIS on 12 of the 21 factors compared between the two stocks. Get STERIS News Delivered to You Automatically Sign up to receive the latest news and ratings for STE and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart STE vs. The Competition Export to ExcelMetricSTERISSurgical appliances & supplies IndustryMedical SectorNYSE ExchangeMarket Cap$22.01B$9.15B$5.56B$18.96BDividend Yield1.01%1.64%5.11%4.03%P/E Ratio47.7019.2722.4432.71Price / Sales4.0971.13393.9527.84Price / Cash15.7319.6738.1817.53Price / Book3.434.956.774.47Net Income$378.24M$284.66M$3.22B$1.02B7 Day Performance-0.81%0.01%1.45%0.50%1 Month Performance-0.37%1.87%3.96%-2.83%1 Year Performance9.56%-17.14%16.07%4.36% STERIS Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)STESTERIS4.5006 of 5 stars$223.14-0.7%$258.75+16.0%+9.8%$21.92B$5.40B47.3816,000Upcoming EarningsShort Interest ↑Positive NewsBDXBecton, Dickinson and Company4.9057 of 5 stars$205.10+0.0%$272.86+33.0%-11.8%$58.89B$20.64B34.0777,000Earnings ReportDividend AnnouncementPositive NewsGap DownEWEdwards Lifesciences4.6048 of 5 stars$75.55-0.6%$79.45+5.2%-10.8%$44.41B$5.25B10.8417,300Short Interest ↓Analyst RevisionPositive NewsIDXXIDEXX Laboratories3.9573 of 5 stars$433.99-0.8%$523.75+20.7%-12.2%$35.17B$3.90B40.6710,800Earnings ReportPositive NewsGap UpRMDResMed4.0268 of 5 stars$234.06-0.8%$258.83+10.6%+10.5%$34.38B$5.02B27.638,160Dividend AnnouncementDXCMDexCom4.9426 of 5 stars$71.18-0.7%$99.00+39.1%-44.0%$27.91B$4.03B49.787,600Positive NewsPODDInsulet4.481 of 5 stars$259.52-0.5%$292.06+12.5%+46.7%$18.23B$2.07B44.822,600Upcoming EarningsAnalyst ForecastNews CoveragePositive NewsBAXBaxter International4.3661 of 5 stars$30.60+1.3%$38.56+26.0%-22.7%$15.70B$10.64B-23.9160,000Earnings ReportNews CoverageGap UpHOLXHologic4.8718 of 5 stars$58.08+0.1%$84.62+45.7%-23.2%$13.03B$4.04B18.326,940Positive NewsGMEDGlobus Medical4.8073 of 5 stars$72.58-0.3%$96.91+33.5%+44.2%$9.98B$2.52B96.772,600Upcoming EarningsShort Interest ↑MASIMasimo3.8021 of 5 stars$164.04+0.2%$194.80+18.8%+19.8%$8.86B$2.09B113.136,200Upcoming EarningsPositive News Related Companies and Tools Related Companies Becton, Dickinson and Company Alternatives Edwards Lifesciences Alternatives IDEXX Laboratories Alternatives ResMed Alternatives DexCom Alternatives Insulet Alternatives Baxter International Alternatives Hologic Alternatives Globus Medical Alternatives Masimo Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:STE) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[Action Required] Claim Your FREE IRS Loophole GuideThis shouldn't surprise anyone who's been paying attention, but... Pres. Trump may be about to unleash the ...Colonial Metals | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredMassive dollar overhaul underway in D.C.?Trump's plan to save the U.S. Dollar The U.S. Dollar is crashing, and our reserve currency status is now in...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding STERIS plc Please log in to your account or sign up in order to add this asset to your watchlist. Share STERIS With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.